Shockwave Therapy Clinical Evidence

Wheeler 2022 | Gr. Trochanteric Pain | RSW

Back to overview

Wheeler PC. Even Patients with Very Chronic Symptoms of Greater Trochanteric Pain Syndrome (GTPS) may Report Improvements Following Radial Extracorporeal Shockwave Therapy (rESWT), but no Single Baseline Factor Predicts Response. Muscles, Ligaments and Tendons Journal. 2022;12(3):411-421.

Retrospective study (level 4) 260 patients with long symptom duration (mean 44.5 months) 3 sessions RSW with Chattanooga Intelect RPW 20 Hz, 2000 pulses, 2.3-3.4 bar (max tolerable) + home exercises. Results: “Average” pain improved about 30% at 3 -months, and 37% at 6-months following rESWT. “Worst pain” improved by 25% at 3 -months, and 30% at 6- months. These improvements reached statistical significance and exceeded the minimally important clinical difference (MCID) in a patient cohort with very long average duration of symptoms. However, there was no single baseline factor that correlated with positive outcome and could have predictive value.

Key message There were clinical and statistically-significant improvements seen following rESWT for patients with GTPS, even in those with very long duration of symptoms

Journal link

Figures

iEnovis

45

© 2022 Enovis Corporation

CONFIDENTIAL

Made with FlippingBook - PDF hosting